Category: Biotechnology

28 March 2025 | ReNerve Limited (ASX: RNV) (“ReNerve” or “the Company”), a medical device company focused on innovative products aimed at nerve repair and regeneration, is pleased to announce positive clinical data demonstrating the significant benefits of using the Company’s NervAlign® Nerve Cuff in peripheral nerve repair surgery. The study results, presented this week … Continued

26 March 2025 – LTR Pharma Limited (ASX:LTP) (“LTR Pharma” or “the Company”) is pleased to provide an update to the Company’s commercial and regulatory processes, highlighting the strong progress that has been made toward the global commercialisation and approvals for its innovative intranasal erectile dysfunction (ED) treatment, SPONTAN®. Highlights Successful FDA pre-IND meeting has … Continued

19 March 2025 | BlinkLab Limited (ASX: BB1) (“BlinkLab” or the “Company”) is pleased to announce its newest partnership with Vrije Universiteit Amsterdam (VU Amsterdam) and the Netherlands Autism Register (NAR) in order to advance research on autism detection in adults.  This study will complement BlinkLab’s ongoing FDA-registration trial for the diagnossis of autism in … Continued

Sydney, Australia – 12 March 2025 | BlinkLab Limited (ASX:BB1) (“BlinkLab” or the “Company”) is pleased to announce that the first patient has been tested in its pivotal U.S. autism diagnostic study, marking the official commencement of the largest digital diagnostic trial for autism in the United States. The trial is designed to validate BlinkLab … Continued

11 March 2025 – Sydney, Australia | ReNerve Limited (ASX:RNV) (“ReNerve” or “the Company”) is pleased to announce key milestones in its Asian market expansion, including marketing approval for the NervAlign® Nerve Cuff™ in Thailand, as well as its first hospital stocking order in Hong Kong. These developments strengthen ReNerve’s commercial presence outside the initial … Continued

LTR Pharma Limited (ASX:LTP) (“LTR Pharma” or “the Company”) is pleased to announce that its Chief Scientific and Clinical Advisor, Professor Eric Chung, will present pivotal SPONTAN® clinical trial data at the Urological Society of Australia and New Zealand (USANZ) Annual Scientific Meeting in Perth, from 1 to 4 March 2025. Highlights 470% Faster Absorption: … Continued

ReNerve Limited (ASX:RNV) (“ReNerve” or “the Company”) is pleased to announce it has signed an exclusive distribution partnership agreement with Imbiomex, a leading Mexican medical device distribution company, in order to progress the NervAlign® Nerve Cuff through regulatory approval and commercial distribution in Mexico. Highlights ReNerve partners with Imbiomex to secure regulatory approval and launch … Continued